David Rowe

Vice President, Business Development - CRISPR Editors

Mr. Rowe is a founder of Excision BioTherapeutics and serves as Vice President of Business Development. He served as Director of Criterion Bioscience Research Group, analyzing various scientific developments to enhance its core advisory products.

David is a Business Development Executive with over fifteen years of experience in providing capital solutions to companies. In this role, he has served companies in establishing various capital structures with private capital sources. The industries he has covered include pharmaceutical, manufacturers and distributors. He has worked extensively with companies to finance their supply chain. He has financed a number of Import/Export transactions to various countries including China, Dubai, Philippines and Kuwait.

His approach to raising capital is to work with established lending institutions to enhance the capital structure of a company. These types of structures enable companies to grow beyond the limitations of a more traditional banking relationship. He has successfully closed over $400 million in transaction financing. David began his career on Wall Street, helping to build one of the largest proprietary equity trading firm’s on Wall Street.